Dianthus Therapeutics Statistics
Total Valuation
DNTH has a market cap or net worth of $693.46 million. The enterprise value is $520.70 million.
Market Cap | 693.46M |
Enterprise Value | 520.70M |
Important Dates
The next estimated earnings date is Friday, May 3, 2024, before market open.
Earnings Date | May 3, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
DNTH has 29.35 million shares outstanding. The number of shares has increased by 489.48% in one year.
Shares Outstanding | 29.35M |
Shares Change (YoY) | +489.48% |
Shares Change (QoQ) | +31.91% |
Owned by Insiders (%) | 15.97% |
Owned by Institutions (%) | 74.01% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 245.52 |
Forward PS | 362.64 |
PB Ratio | 4.11 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 184.25 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.43, with a Debt / Equity ratio of 0.00.
Current Ratio | 18.43 |
Quick Ratio | 18.09 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.90% and return on invested capital (ROIC) is -28.43%.
Return on Equity (ROE) | -34.90% |
Return on Assets (ROA) | -32.60% |
Return on Capital (ROIC) | -28.43% |
Revenue Per Employee | $53,321 |
Profits Per Employee | -$821,792 |
Employee Count | 53 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 25.71 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 45.97 |
Average Volume (30 Days) | 164,091 |
Short Selling Information
The latest short interest is 1.39 million, so 4.74% of the outstanding shares have been sold short.
Short Interest | 1.39M |
Short Previous Month | 1.07M |
Short % of Shares Out | 4.74% |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.19 |
Income Statement
In the last 12 months, DNTH had revenue of $2.83 million and -$43.56 million in losses. Loss per share was -$8.45.
Revenue | 2.83M |
Gross Profit | 2.83M |
Operating Income | -48.17M |
Pretax Income | -43.56M |
Net Income | -43.56M |
EBITDA | -43.20M |
EBIT | -43.56M |
Loss Per Share | -$8.45 |
Balance Sheet
The company has $173.72 million in cash and $585,000 in debt, giving a net cash position of $173.13 million or $5.90 per share.
Cash & Cash Equivalents | 173.72M |
Total Debt | 585,000 |
Net Cash | 173.13M |
Net Cash Per Share | $5.90 |
Equity / Book Value | 168.87M |
Book Value Per Share | 5.75 |
Working Capital | 167.82M |
Cash Flow
In the last 12 months, operating cash flow was -$36.86 million and capital expenditures -$110,000, giving a free cash flow of -$36.97 million.
Operating Cash Flow | -36.86M |
Capital Expenditures | -110,000 |
Free Cash Flow | -36.97M |
FCF Per Share | -$7.17 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,704.67% and -1,541.22%.
Gross Margin | 100.00% |
Operating Margin | -1,704.67% |
Pretax Margin | -1,541.22% |
Profit Margin | -1,541.22% |
EBITDA Margin | -1,528.66% |
EBIT Margin | -1,541.22% |
FCF Margin | -1,308.24% |
Dividends & Yields
DNTH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -489.48% |
Shareholder Yield | -489.48% |
Earnings Yield | -6.28% |
FCF Yield | -5.33% |
Analyst Forecast
The average price target for DNTH is $41.75, which is 76.98% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $41.75 |
Price Target Difference | 76.98% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 12, 2023. It was a reverse split with a ratio of 1:16.
Last Split Date | Sep 12, 2023 |
Split Type | Reverse |
Split Ratio | 1:16 |
Scores
DNTH has an Altman Z-Score of 39.16 and a Piotroski F-Score of 3.
Altman Z-Score | 39.16 |
Piotroski F-Score | 3 |